Benitec Biopharma Inc. Form 8-K12B: Current report of a successor issuer (Section 12(b))
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2020-04-15: Form 8-K12B; Period of report 2020-04-15; Description 8-K12B; Document bntc-8k12b_20200415.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2020-04-15 | 8-K12B | 2020-04-15 | 8-K12B | bntc-8k12b_20200415.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |